Yihuan Chen et al. demonstrated that the collagen family, especially COL1A1, COL1A2, and COL12A1, might act as potential prognostic biomarkers and immune-associated therapeutic targets in gastric cancer [75]. Here, COL1A1 is linked to gastric cancer.